Clinical trial
Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients…
NCT00425841 · Technical University of Munich, Other · Completed
Key facts
| NCT number | NCT00425841 |
|---|---|
| Title | Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer |
| Official title | Lokal Fortgeschrittenes Pankreas-Karzinom: Stereotaktische Radiotherapie Gefolfgt Von Gemox-Chemotherapie |
| Lead sponsor | Technical University of Munich, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | gemcitabine hydrochloride, oxaliplatin, adjuvant therapy, neoadjuvant therapy, hypofractionated radiation therapy, stereotactic radiosurgery |
| Enrollment | 29 |
| Start date | May 1, 2006 |
| Completion | Dec 1, 2009 |
| First posted | Jan 23, 2007 |
| Last update posted | Dec 12, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: